|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 239/54 | |
| A61K 31/522 | |||
| A61P 31/14 | |||
| B01J 31/24 | |||
| A61K 31/7056 | |||
| A61K 31/513 | |||
| A61K 45/06 | |||
| A61K 38/21 |
| (11) | Number of the document | 3056486 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16158981.7 |
| Date of filing the European patent application | 2011-07-15 | |
| (97) | Date of publication of the European application | 2016-08-17 |
| (45) | Date of publication and mention of the grant of the patent | 2018-07-11 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 365293 P | 2010-07-16 | US | |
| 201161444475 P | 2011-02-18 | US |
| (72) |
SHEKHAR, Shashank, US
FRANCZYK, Thaddeus S., US
BARNES, David M., US
DUNN, Travis B., US
HAIGHT, Anthony R., US
CHAN, Vincent S., US
|
| (73) |
AbbVie Ireland Unlimited Company,
70 Sir John Rogerson`s Quay, Dublin 2,
IE
|
| (54) | PROCESS FOR PREPARING INTERMEDIATES FOR ANTIVIRAL COMPOUNDS |
| PROCESS FOR PREPARING INTERMEDIATES FOR ANTIVIRAL COMPOUNDS |